Insulin Glargine (U-100) Vials and Natalizumab Intravenous
Determining the interaction of Insulin Glargine (U-100) Vials and Natalizumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: natalizumab
Brand name: Tysabri
Synonyms: Natalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Vials-Natalvirt 90 DHA
- Insulin Glargine (U-100) Vials-Natalvirt CA
- Insulin Glargine (U-100) Vials-Natazia
- Insulin Glargine (U-100) Vials-Nateglinide
- Insulin Glargine (U-100) Vials-Natelle Complete
- Insulin Glargine (U-100) Vials-Natelle One
- Natalizumab Intravenous-Insulin Glargine (U-300) Pens
- Natalizumab Intravenous-Insulin glargine and lixisenatide
- Natalizumab Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Natalizumab Intravenous-Insulin glargine, recombinant Subcutaneous
- Natalizumab Intravenous-Insulin glulisine
- Natalizumab Intravenous-Insulin Glulisine (Cartridges and Pens)